Filana Therapeutics
FLNA
23 hedge funds and large institutions have $2.21M invested in Filana Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
8.88% less ownership
Funds ownership: 19.47% → 10.6% (-8.9%)
12% less funds holding
Funds holding: 26 → 23 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
46% less capital invested
Capital invested by funds: $4.07M → $2.21M (-$1.87M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$217K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$80.9K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$30.9K |
| 4 |
Jane Street
New York
|
+$18K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.78K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
-$2.05M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$46K |
| 3 |
VF
Virtu Financial
New York
|
-$25K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$23K |
| 5 |
JP Morgan Chase
New York
|
-$17K |
FLNA Hedge Fund Activity: Q3 2019 in Review
23 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2019, worth a combined $2.21M — down 46% from $4.07M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of FLNA and 4 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $217K. The largest seller was First Eagle Investment Management, exiting entirely with an estimated $2.05M sold.
- 23 institutional investors held Filana Therapeutics (FLNA) as of Q3 2019, down from 26 in Q2 2019.
- Funds reported $2.21M of Filana Therapeutics stock for Q3 2019, down 46% quarter-over-quarter.
- 4 funds opened new Filana Therapeutics positions in Q3 2019 and 7 closed out, a net change of -3 holders.
- The largest Filana Therapeutics buyer in Q3 2019 was Renaissance Technologies, an estimated $217K added.
- The largest Filana Therapeutics seller in Q3 2019 was First Eagle Investment Management, an estimated $2.05M sold.
Based on aggregated 13F filings for Q3 2019.